These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15016555)

  • 41. Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma.
    Holmstrom S; Buchholz P; Walt J; Wickstrøm J; Aagren M
    Curr Med Res Opin; 2005 Nov; 21(11):1875-83. PubMed ID: 16307709
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost.
    Hart J; Shafranov G
    Am J Ophthalmol; 2004 Apr; 137(4):756-7. PubMed ID: 15059720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomised crossover study comparing bimatoprost and latanoprost in subjects with primary angle closure glaucoma.
    How AC; Kumar RS; Chen YM; Su DH; Gao H; Oen FT; Ho CL; Seah SK; Aung T
    Br J Ophthalmol; 2009 Jun; 93(6):782-6. PubMed ID: 19336424
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Corneal sensitivity changes following the instillation of latanoprost, bimatoprost, and travoprost eyedrops.
    Kozobolis VP; Detorakis ET; Maskaleris G; Koukoula SC; Fountoulakis N; Chrysochoou F; Konstas AG
    Am J Ophthalmol; 2005 Apr; 139(4):742-3. PubMed ID: 15808188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contact dermatitis from topical bimatoprost.
    Sodhi PK; Verma L; Ratan SK
    Contact Dermatitis; 2004 Jan; 50(1):50. PubMed ID: 15059112
    [No Abstract]   [Full Text] [Related]  

  • 46. The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy.
    Sharpe ED; Reynolds AC; Skuta GL; Jenkins JN; Stewart WC
    Curr Eye Res; 2007 Dec; 32(12):1037-43. PubMed ID: 18085467
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of bimatoprost as replacement for latanoprost in patients with glaucoma or ocular hypertension: a uniocular switch study.
    Casson RJ; Liu L; Graham SL; Morgan WH; Grigg JR; Galanopoulos A; Crawford A; House PH
    J Glaucoma; 2009; 18(8):582-8. PubMed ID: 19826386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertension.
    Walt JG; Lee JT
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S36-44. PubMed ID: 15016560
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased high-density lipoprotein serum levels associated with topical bimatoprost therapy.
    Steinhäuser SL
    Optometry; 2006 Apr; 77(4):177-9. PubMed ID: 16567279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.
    Denis P; Lafuma A; Khoshnood B; Mimaud V; Berdeaux G
    Curr Med Res Opin; 2007 Mar; 23(3):601-8. PubMed ID: 17355741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bilateral nongranulomatous anterior uveitis associated with bimatoprost.
    Packer M; Fine IH; Hoffman RS
    J Cataract Refract Surg; 2003 Nov; 29(11):2242-3. PubMed ID: 14670442
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New drugs for glaucoma.
    FDA Consum; 2001; 35(3):4. PubMed ID: 11458549
    [No Abstract]   [Full Text] [Related]  

  • 53. Prostaglandin analogues in angle closure glaucoma.
    Gupta P; Mahesh BS; Gupta HL
    Indian J Ophthalmol; 2011; 59(5):411-2. PubMed ID: 21836364
    [No Abstract]   [Full Text] [Related]  

  • 54. [For 150 years it is possible to treat glaucoma with intraocular pressure reducing drugs].
    Erb C
    Klin Monbl Augenheilkd; 2013 Feb; 230(2):113. PubMed ID: 23430675
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment of glaucoma with catapresan].
    Honegeer H; Wachholz E
    Klin Monbl Augenheilkd; 1971 Feb; 158(2):306-7. PubMed ID: 5555611
    [No Abstract]   [Full Text] [Related]  

  • 56. [Catapresan (2-(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride)--a new intraocular pressure lowering agent].
    Hasslinger C
    Klin Monbl Augenheilkd; 1969 Jan; 154(1):95-105. PubMed ID: 5364293
    [No Abstract]   [Full Text] [Related]  

  • 57. [Phonophoresis of hypotensive agents in the treatment of simple glaucoma].
    Cherkasov IS; Marmur RK; Radkovskaia AIa; Loskova LM
    Oftalmol Zh; 1974; 29(2):114-8. PubMed ID: 4840548
    [No Abstract]   [Full Text] [Related]  

  • 58. [Malar and ciliary hypertrichosis induced by bimatoprost].
    Rouxel AM; Roguedas-Contios AM; Misery L
    Ann Dermatol Venereol; 2007 Oct; 134(10 Pt 1):780-1. PubMed ID: 17978721
    [No Abstract]   [Full Text] [Related]  

  • 59. In search of improved prostaglandin treatment for glaucoma.
    Thygesen J
    Acta Ophthalmol Suppl (Oxf ); 2008; 242():5-6. PubMed ID: 18752508
    [No Abstract]   [Full Text] [Related]  

  • 60. New drugs 2002, part 1.
    Hussar DA
    Nursing; 2002 Jan; 32(1):52-8; quiz 59. PubMed ID: 12352750
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.